- Home
- ZCMD vs LTRN Comparison
ZCMD vs LTRN Comparison
Compare ZCMD & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- LTRN
- Stock Information
- Founded
- ZCMD 2012
- LTRN 2013
- Country
- ZCMD China
- LTRN United States
- Employees
- ZCMD N/A
- LTRN N/A
- Industry
- ZCMD Other Consumer Services
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- LTRN Health Care
- Exchange
- ZCMD Nasdaq
- LTRN Nasdaq
- Market Cap
- ZCMD 29.0M
- LTRN 36.0M
- IPO Year
- ZCMD 2020
- LTRN 2020
- Fundamental
- Price
- ZCMD $1.22
- LTRN $3.12
- Analyst Decision
- ZCMD
- LTRN Strong Buy
- Analyst Count
- ZCMD 0
- LTRN 1
- Target Price
- ZCMD N/A
- LTRN $25.00
- AVG Volume (30 Days)
- ZCMD 648.0K
- LTRN 51.1K
- Earning Date
- ZCMD 01-01-0001
- LTRN 08-07-2025
- Dividend Yield
- ZCMD N/A
- LTRN N/A
- EPS Growth
- ZCMD N/A
- LTRN N/A
- EPS
- ZCMD N/A
- LTRN N/A
- Revenue
- ZCMD $15,864,773.00
- LTRN N/A
- Revenue This Year
- ZCMD N/A
- LTRN N/A
- Revenue Next Year
- ZCMD N/A
- LTRN N/A
- P/E Ratio
- ZCMD N/A
- LTRN N/A
- Revenue Growth
- ZCMD N/A
- LTRN N/A
- 52 Week Low
- ZCMD $0.95
- LTRN $2.55
- 52 Week High
- ZCMD $2.97
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- ZCMD 53.68
- LTRN 43.98
- Support Level
- ZCMD $1.06
- LTRN $3.05
- Resistance Level
- ZCMD $1.28
- LTRN $3.24
- Average True Range (ATR)
- ZCMD 0.17
- LTRN 0.17
- MACD
- ZCMD 0.00
- LTRN 0.01
- Stochastic Oscillator
- ZCMD 54.02
- LTRN 15.64
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.